Their Genomic Unity® test uses clinical whole genome sequencing to identify all major variant types from a single patient sample, eliminating the need for traditional step-wise genetic testing. Variantyx's whole-genome sequencing platform simplifies sample collection, DNA extraction and sequencing, data analysis, interpretation and clinical reporting by automating them, enabling hospital and commercial labs to expand their test menu with validated genomic diagnostic solutions. Overall, Variantyx provides state-of-the-art diagnostic solutions for rare genetic disorders and reproductive genetics markets, and treatment optimization in oncology.